• Guideline Summary
  • NGC:010715
  • 2005 Feb 17 (revised 2015 Mar 31)

Rituximab in lymphoma and chronic lymphocytic leukemia: a clinical practice guideline, version 3.

  • Guideline Summary
  • NGC:010824
  • 2015 Sep 15

Plerixafor for autologous hematopoietic stem cell mobilization and transplantation for patients in Ontario.

  • Guideline Summary
  • NGC:009868
  • 2012 Jun 15

The role of liver resection in colorectal cancer metastases.

  • Guideline Summary
  • NGC:009865
  • 2012 Mar 29

Stem cell transplantation in multiple myeloma.

  • Guideline Summary
  • NGC:010003
  • 2006 Apr 3 (revised 2013 Mar 18)

Bortezomib in multiple myeloma and lymphoma.

  • Guideline Summary
  • NGC:010700
  • 2014 Sep 30

Optimal systemic therapy for early female breast cancer.

  • Guideline Summary
  • NGC:009857
  • 2000 Dec 6 (revised 2011 Apr 5)

Neoadjuvant or adjuvant therapy for resectable gastric cancer.

  • Guideline Summary
  • NGC:010004
  • 2013 May 13

Routine HPV testing in head and neck squamous cell carcinoma.

  • Guideline Summary
  • NGC:010557
  • 2014 Aug 29

Follow-up and surveillance of curatively treated lung cancer patients.

  • Guideline Summary
  • NGC:009867
  • 2012 Mar 29

Stem cell transplantation in primary systemic amyloidosis.

  • Guideline Summary
  • NGC:010884
  • 2015 Dec 8

Management of early-stage Hodgkin lymphoma.

  • Guideline Summary
  • NGC:009789
  • 2012 May 30

Lenalidomide in multiple myeloma.

  • Guideline Summary
  • NGC:009862
  • 2011 Aug 15

Radionuclide therapy for neuroendocrine malignancies.

  • Guideline Summary
  • NGC:009866
  • 2012 Mar 29

Stem cell transplantation in myelodysplastic syndromes and acute myeloid leukemia.

  • Guideline Summary
  • NGC:010223
  • 2012 Oct 31

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer.

  • Guideline Summary
  • NGC:010225
  • 2013 Nov 27

The prognostic value of the DNMT3A biomarker in cytogenetically normal patients with acute myeloid leukemia.